PREMIERE registry: long-term safety registry of multiple sclerosis patients from cladribine clinical trials
PREMIERE registry: Prospective observational long-term safety registry of Multiple Sclerosis patients who have participated in cladribine clinical trials. Purpose is to produce long-term safety data on oral cladribine in multiple sclerosis (MS).
premiere, cladribine, safety, registry, EMR700568-012, 700568012, EMD, Merck, Serono, MS, Multiple, Sclerosis
Last Update: MEZ/CET 26.07.2017, 00:07:00 Uhr